NCT00546494View on ClinicalTrials.gov

Study Evaluating Effexor® (Venlafaxine) in Achieving Response and Maintaining Remission

PHASE4CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

March 31, 2005

Conditions
Depression
Interventions
DRUG

Effexor® (Venlafaxine)

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00546494 - Study Evaluating Effexor® (Venlafaxine) in Achieving Response and Maintaining Remission | Biotech Hunter | Biotech Hunter